Answers are grounded in this paper and cite their sources.
We identified a novel mechanism by which tumor immune evasion is regulated by p53/miR-34/PDL1 axis. Our results suggest that delivery of miRNAs with standard therapies, such as XRT, may represent a novel therapeutic approach for lung cancer.
No takes yet. Share an insight, caveat, or question.
Cortez et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: